4.5 Article

SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis

期刊

JOURNAL OF LEUKOCYTE BIOLOGY
卷 90, 期 3, 页码 483-492

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1189/jlb.0311124

关键词

inflammatory bowel disease; phenotype; m phi; intestinal inflammation

资金

  1. Crohn's and Colitis Foundation of Canada
  2. Canadian Association of Gasotrenterology/Canadian Institute of Health Research/Crohn's and Colitis Foundation of Canada

向作者/读者索取更多资源

m phi are heterogeneous in their functions, and although it is clear that inflammatory m phi contribute to inflammation in IBDs, multiple lines of evidence suggest that M2a m phi may offer protection during intestinal inflammation. In vivo SHIP-deficient mouse m phi are M2a so SHIP-deficient mice provide a unique genetic model of M2a m phi. Based on this, this study tested the hypothesis that SHIP-deficient, M2a m phi protect mice from intestinal inflammation. The objectives were to compare the susceptibility of SHIP+/+ and SHIP-/- littermates with DSS-induced intestinal inflammation and to determine whether protection was m phi-mediated and whether protection could be transferred to a susceptible host. We have found that SHIP-/- mice are protected during DSS-induced intestinal inflammation. SHIP-/- mice have delayed rectal bleeding and reduced weight loss, disruption of intestinal architecture, and immune cell infiltration during DSS-induced colitis relative to their WT littermates. Using liposome depletion of m phi, we found that SHIP-/- mouse protection was indeed m phi-mediated. Finally, we determined that SHIP-/- m phi-mediated protection could be conferred to susceptible WT mice by adoptive transfer of M2a m phi derived ex vivo. This study supports our hypothesis by demonstrating that SHIP-deficient, M2a m phi are protective in this murine model of acute intestinal inflammation. Adoptive transfer of M2a m phi to patients with IBDs offers a promising, new strategy for treatment that may be particularly useful in patients who are otherwise refractory to conventional therapies. J. Leukoc. Biol. 90: 483-492; 2011.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据